PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
October 17, 2013 | ISSUE NUMBER 321 VOL 11

Online
Wikipedia is a Public Health Issue — We Need to Fix It
Medical articles on Wikipedia receive about 150 million page views per month, and nearly 50% of practicing physicians use Wikipedia as an information source for providing medical care. And while Wikipedia itself has disclaimers that information included on its site may be inaccurate, that doesn’t stop consumers and medical professionals alike from using it as a health source that they consider credible. What should we do? ...Read more

Online
Wikipedia — Also a Pharma Marketing Issue
A 2011 survey of hundreds of doctors across Europe put the number using Wikipedia as high as 60 percent. Peter Houston asks why ...Read more

Transparency
Putting a Price Tag on Compliance: Cheap Change or Big Bucks?
Compliance rules under the US Physician Payments Sunshine Act have been criticized for the excruciating level of detail demanded from individual company submissions.  But relatively little scrutiny has been accorded to another pressing question: how much will all this new reporting cost?
...Read more

ZS Associates – Four Key Health Care Trends Impacting Pharma
Companies that can spot and capitalize on these trends will enjoy long-term competitive advantages. So here’s a quick look around the corner.

Global
Who Dares to Stop the European Transparency Bandwagon?
The research-based industry in Europe is moving out of the way the unstoppable transparency juggernaut, hoping at best to nudge it into a less damaging direction as it roars past. But two companies are resisting the trend and have stepped straight into its path, shouting: "Stop!"
...Read more

Pharmaceutical Executive editorial staff proudly introduces PharmExec TV, their latest high quality pertinent content in a brand new industry-breaking format.Tune In Now.

Video
Structural Forces Impacting the Pharmaceutical Industry
In this new episode of PharmExec TV, Patrick Lindsay, President of UBC sits down with Editorial Director William Looney to discusses the challenges and opportunities offering support to pharmaceutical companies
...View here

New E-Book- Lifecycle Solutions: Positioning Pharmaceuticals For Commercial Success
Time is risk. If time to market is slowed then the cost for a company is lost revenues, profits, and ultimately lost opportunities for patients. The message is clear. To compete and win, companies must wrest more value from every stage of a new product’s tightly projected lifecycle.Download Now

Event
Forbes Health Summit: Industry Leaders Ponder the New World of Consumer-Driven Care
In healthcare, it is the lowly consumer who is now calling the shots, driving product and process innovation in areas ranging from electronic medical records (EMR) to retail health clinics. This was the main theme among discussants at the Forbes magazine Healthcare Summit held in New York on October 10. The central question:  in an era of proliferating choices in health care, how and where do all the pieces fit in, and to what end?
...View here

Pharma’s Shift to Custom Solutions Marketing.
Leveraging Custom Digital Solutions to Engage Targeted Physician/HCP Audiences

Live Webinar: Thursday, October 31, 2013 at 11:00 am ET
Register Free at www.pharmexec.com/custom.

New eBook
Lifecycle Solutions: Positioning Pharmaceuticals For Commercial Success
Pharmaceutical brand marketers are facing a paradigm shift in the way they market patient access solutions. As they navigate through the dynamics of a regionalized market, shrinking budgets and the challenges of tactical implementation, they require a consultative relationship with vendor providers. The question then is: Can the pharmaceutical marketer rely on one vendor to deliver customized, innovative solutions over the life of their brand?
...Read more

//INC Research (Raleigh, NC) appointed Dr Martin Sullivan as its new Executive Director for cardiovascular medicine.//EUSA Pharma Founder and former CEO Bryan Morton joined UK-based Glide Pharma as Non-Executive Chairman.//Ogilvy CommonHealth Worldwide (Parsippany, NJ) announced that Gary Pattison has been appointed Group Managing Director of its Australian division.//

November 13–14: Sponsor/CRO and Business Process Integration
Raleigh, NC.


November 13–15: 2013 HBA Leadership Conference
Boston, MA.


January 28–29, 2014: 11th Annual Pharmaceutical Compliance Congress
Washington, DC.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin

 

Survey
Should government funding for the US National Institutes of Health be exempted from federal budget sequestration cuts, debt ceiling negotiations and future government shutdowns?

Click To Vote
 

Quick Links

Not Much Ado About the ACA

Market Access is Dead

Closed-Loop Marketing: Where Next?